Investment
Features
FeesSafety
Academy
More
Pluang+

Compare McDonald's Corp (MCD) vs Medtronic PLC (MDT) Price & Performance

McDonald's CorpTrade
Medtronic PLCTrade

Price performance (Past 24H)

Key statistics

McDonald's Corp vs Medtronic PLC — how do they compare? McDonald's Corp trades at $264.29 (market cap $190.16B), while Medtronic PLC trades at $82.23 (market cap $106.61B). The key difference: McDonald's Corp is the larger of the two by market cap, and Medtronic PLC pays the higher dividend (3.46%). Which is the better fit depends on your goals.

MCDMDT
Market Cap
$190.16B$106.61B
Volume
2,230,036
Sector
Consumer CyclicalHealth
52-Week High
$341.06$105.35
52-Week Low
$264.54$73.75
Enterprise Value
$243.87B$125.36B
Dividend Yield
2.78%3.46%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

McDonald's Corp

McDonald's (MCD) trades at $267.71, down 2.1% on the day, with a bearish technical signal driven by moving averages. The company reported steady revenue growth to $26.89 billion in 2025 and a net income margin of 31.62%, though Q2 2026 earnings are pending. Recent news highlights a new 'McDonald's NEXT' strategy focusing on automation and menu improvements to boost competitiveness.

The stock presents a buying opportunity with a consensus price target of $329, implying 23% upside, supported by strong analyst sentiment (58% buy ratings). Risks include inflationary pressures on franchisee margins and high long-term debt of $38.42 billion. Earnings execution and strategy rollout will be key for near-term performance.

Medtronic PLC

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About McDonald's Corp

McDonald's Corporation franchises and operates fast-food restaurants in the global restaurant industry. The Company's restaurants serves a variety of value-priced menu products in countries around the world.

Read more on MCD

About Medtronic PLC

One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.

Read more on MDT